CMS Open Payments · Program Year 2024
Sysmex America, Inc.
Sysmex America, Inc. reported $83,677.46 across General Payments, Research, and Ownership to 38 physicians and teaching hospitals across 40 transactions.
- $83.7K Below-median payer
- All-tracks total
- 40 Below-median volume
- Transactions
- 38 Below-median reach
- Recipients
- −$28.7K
- General Payments vs PY2023
Sysmex America, Inc. reported $83,677.46 across all CMS Open Payments tracks (General + Research + Ownership) to 38 physicians and teaching hospitals in Program Year 2024 - ranking #1229 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $54,427.46, averaging $2.2K per recipient.
How Sysmex America, Inc.'s $83.7K all-tracks total breaks down
Sysmex America, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
30/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer sysmex-america-inc Sysmex America, Inc.
$83.7K · #1229/1,925 · 0.0% industry · PY2024
- TOT $83.7K
- RANK #1229
- SHARE 0.0%
- TXN 40
- RCP 38
- CAT 7
- GEN $54.4K
- ΔGEN −$28.7K
- TOP1 37.9%
- PY 2024
Volume peers
Nearest volume peer: Stratus Medical, LLC ($83.5K)
Sysmex America, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Sysmex America, Inc.'s CMS-reported General Payments decreased by $28.7K (−34.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SYSMEX AMERICA, INC.PY2023: SYSMEX AMERICA, INC.PY2024: Sysmex America, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $83,132.29
- PY2024
- $54,427.46
What the Data Shows for Sysmex America, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Sysmex America, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
12 transactions worth $24.7K make "Honoraria" the top general-payment category in the 7-category breakdown below, 45.3% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Honoraria" leads Sysmex America, Inc.'s 7-category general-payment breakdown at $24.7K, 45.3% of the reported total.
Sysmex America, Inc. reports 7 general-payment categories - the top three are Honoraria (45.3%), Consulting Fee (36.7%), and Charitable Contribution (6.5%). The remaining 4 categories make up 11.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Sysmex America, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $24.7K | 12 | 45.3% |
| Consulting Fee | $20.0K | 4 | 36.7% |
| Charitable Contribution | $3.6K | 2 | 6.5% |
| Space Rental or Facility Fees | $3.0K | 1 | 5.5% |
| Travel and Lodging | $2.3K | 9 | 4.2% |
| Food and Beverage | $695.56 | 9 | 1.3% |
| Compensation for Services Other Than Consulting | $250.00 | 1 | 0.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $34,526.41 (63.4%) of $54,427.46 in this company's General Payments records across 21 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Sysmex America, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Carlo Brugnara
$20,612.91 across 8 reported transactions
- 2
Parul Bhargava
$4,000.00 across 2 reported transactions
- 3
Univ Of Mi Hospitals & Hlth Ctrs
$3,500.00 across 1 reported transactions
- 4
Melissa M Ulas
$3,414.50 across 5 reported transactions
- 5
Mayo Clinic Hospital
$2,999.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Sysmex America, Inc. ranks #1229 of 1,925 by total payments (bottom 36% by spend) but is notably more concentrated than that alone would suggest -- #799 of 1,838 by HHI (top 43% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Lazarus 3D : $1.2K total payments, HHI 1788
- exocad America, Inc. : $54.9K total payments, HHI 1781
- Citieffe, Inc. : $145.4K total payments, HHI 1775
- Diagnostica Stago, Inc : $49.4K total payments, HHI 1775
- Cerus Corporation : $405.7K total payments, HHI 1771
- Brixton Biosciences, Inc. : $36.4K total payments, HHI 1756
- Sysmex America, Inc. (this company) : $54.4K total payments, HHI 1755
- bluebird bio, Inc. : $208.3K total payments, HHI 1750
- Pfizer International LLC : $197.5K total payments, HHI 1747
- NextStep Arthropedix, LLC : $125.7K total payments, HHI 1747
- Greiner Bio-One North America, Inc. : $11.6K total payments, HHI 1746
- CashFlow Solutions, LLC : $89.2K total payments, HHI 1745
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Sysmex America, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Sysmex America, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Sysmex America, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Collagen Matrix, Inc
Global Kinetics USA Corporation
Tricoast Surgical Solutions LLC
Pramand LLC
Amplitude Vascular Systems, Inc.
Put this to use
Sysmex America, Inc. ranks #1229 of 1,925 by all-tracks total payments, led by "Honoraria".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Honoraria" spend across every manufacturer, not just Sysmex America, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.